Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.
We determined the MICs of difloxacin (A-56619) and A-56620 against anaerobic bacteria and assessed the effects of alterations in pH, size of inoculum, addition of human serum, and repeated exposure to subinhibitory levels of antibiotics. We tested for synergism of these drugs with cefoxitin against...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1987
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174790/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3606066/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.4.619 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|